Discrimination between patients with mild Alzheimer's disease and healthy subjects based on cerebral blood flow images of the lateral views in xenon-enhanced computed tomography

scientific article

Discrimination between patients with mild Alzheimer's disease and healthy subjects based on cerebral blood flow images of the lateral views in xenon-enhanced computed tomography is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/PSYG.12281
P698PubMed publication ID28745443

P2093author name stringXin Tan
Yutaka Sawa
Shigeru Sase
Ena Kawashima
Homaro Yamamoto
P2860cites workDiscrimination Between Patients With Alzheimer Disease and Healthy Subjects Using Layer Analysis of Cerebral Blood Flow and Xenon Solubility Coefficient in Xenon-Enhanced Computed TomographyQ47296558
Positron emission tomography in Alzheimer's diseaseQ48328045
Determination of time-course change rate for arterial xenon using the time course of tissue xenon concentration in xenon-enhanced computed tomographyQ48482856
Quantitative cerebral blood flow calculation method using white matter lambda in xenon CT.Q48601054
320-slice CT neuroimaging: initial clinical experience and image quality evaluationQ48741576
Incidence and survival of dementia in a general population of Japanese elderly: the Hisayama studyQ48852983
In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomographyQ48967711
Local cerebral blood flow measured by CT after stable xenon inhalation.Q51875225
Pulmonary function affects the quantification of rCBF by non-invasive xenon methods.Q52080139
A new clinical scale for the staging of dementia.Q52220854
Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETaQ53295731
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseQ24595802
“Mini-mental state”Q25938989
Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery diseaseQ28222197
The Clinical Dementia Rating (CDR): current version and scoring rulesQ29616280
Brain metabolism in Alzheimer's dementia: studies of 11C-deoxyglucose accumulation, CSF monoamine metabolites and neuropsychological test performance in patients and healthy subjectsQ33589643
Dominantly inherited Alzheimer's disease: cerebral glucose metabolismQ33628634
Computed tomography dose assessment for a 160 mm wide, 320 detector row, cone beam CT scannerQ34169763
Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: a Markov model simulationQ35454453
Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapyQ36588166
Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's diseaseQ36814980
Alzheimer's disease: strategies for disease modificationQ37739810
Is brain SPECT useful in degenerative dementia diagnosis?Q37821218
Discrepancy of xenon concentrations between end-tidal and blood collection methods in xenon-enhanced computed tomographic measurement of cerebral blood flowQ43556062
Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer typeQ44601832
P433issue1
P921main subjectcerebral blood flowQ5064096
Alzheimer's diseaseQ11081
P304page(s)3-12
P577publication date2017-07-26
P1433published inPsychogeriatrics : the official journal of the Japanese Psychogeriatric SocietyQ27020360
P1476titleDiscrimination between patients with mild Alzheimer's disease and healthy subjects based on cerebral blood flow images of the lateral views in xenon-enhanced computed tomography
P478volume18

Reverse relations

Q58599968Role of GTPases in the Regulation of Mitochondrial Dynamics in Alzheimer's Disease and CNS-Related Disorderscites workP2860

Search more.